Get our news on your inbox! x

Remember me Forgot password

MercoPress, en Español

Montevideo, June 20th 2026 - 11:57 UTC

Tag: Anvisa

  • Tuesday, June 9th 2026 - 07:43 UTC

    Brazil suspends its dengue vaccine as a precaution after two deaths

    The vaccine was approved by the regulatory agency ANVISA in late 2025 for people aged 12 to 59, and the campaign began in February with health personnel

    Brazil temporarily suspended the dengue vaccination campaign it began in January, after detecting two deaths and several cases of serious adverse reactions. The vaccine, the world's first single-dose shot, was developed by the Butantan Institute in São Paulo and had already been given to half a million people through the public health system. Health authorities stressed that there is not yet enough data to link the deaths to the product and that the interruption is a preventive measure.

  • Tuesday, January 13th 2026 - 10:22 UTC

    Brazil's health watchdog gives nod to HIV vaccine

    The biyearly drug is indicated for people aged 12 or over, weighing at least 35 kilos, at risk of catching the virus

    Brazil's Health Regulatory Agency (Anvisa) approved on Monday the use of the drug Sunlenca (lenacapavir) for HIV-1 prevention as pre-exposure prophylaxis (PrEP), Agencia Brasil reported.

  • Thursday, May 1st 2025 - 09:24 UTC

    Brazilian digital platforms banned from advertising vaping devices

    “Our goal is to ensure that the digital environment respects legislation and promotes consumer safety,” Correa said

    Brazil's National Consumer Secretary (Senacon) has ordered digital platforms, including YouTube, Instagram, TikTok, Enjoei, and Mercado Livre, to remove advertisements promoting or selling electronic cigarettes (vapes) and other tobacco-derived products within 48 hours. This directive follows Brazil's continued ban on these products, upheld by the National Health Surveillance Agency (Anvisa) in April 2025.

  • Thursday, April 24th 2025 - 18:14 UTC

    Brazil's sanitary watchdog greenlights drug to treat Alzheimer's

    Anvisa will monitor the safety and effectiveness of donanemabe under strict scrutiny

    Brazil's National Health Surveillance Agency (Anvisa) has approved the use of the drug donanemabe to slow the progression of Alzheimer's disease in patients with mild cognitive impairment and mild dementia. It works by targeting beta-amyloid plaques in the brain, which are associated with the malady.

  • Monday, March 10th 2025 - 15:55 UTC

    Brazil's Anvisa approves weekly insulin to treat diabetes 1 and 2

    One weekly shot of the new drug is said to achieve the same results as current daily injections

    Brazil's National Health Surveillance Agency (Anvisa) has approved the drug Awiqli, produced by the pharmaceutical company Novo Nordisk, to treat adult patients with type 1 and 2 diabetes, Agencia Brasil reported. It is the first weekly insulin shot in the world. There is no date for launching it nationwide.

  • Wednesday, June 26th 2024 - 18:04 UTC

    Brazil's STF decriminalizes marijuana consumption

    Marijuana consumption will remain an administrative offense until other branches of government agree on the maximum amount marking the difference between personal use and traffic

    Brazil's Supreme Federal Court (STF) issued a ruling Tuesday decriminalizing marijuana consumption for personal use, albeit only in private places. As per Brazil's current legislation dating back to 2006, the unauthorized acquisition or transport of drugs for personal use including marijuana carried penalties. Drug use in public areas has been maintained. Another debate revolved around how much marijuana would signal the difference between users and dealers. The case reached the STF following an appeal filed by a prison inmate hiding 3 grams of marijuana in his cell.

  • Friday, April 12th 2024 - 22:20 UTC

    Brazil accounts for nearly 70% of dengue cases in LatAm and Caribbean

    Still, Brazil has reduced the number of deaths in the current dengue epidemic from previous years

    According to a survey conducted by the Pan American Health Organization (PAHO), Brazil accounted for almost 70% of dengue cases in Latin America and the Caribbean, where some 4.6 million infections were confirmed this year, representing a 237% interannual increase, Agencia Brasil reported. PAHO is the arm of the World Health Organization (WHO) in the Americas.

  • Monday, April 1st 2024 - 19:54 UTC

    Brazilian VP down with Covid-19

    Alckmin was said to be doing well after showing mild symptoms of the malady

    Brazil's Vice President Geraldo Alckmin stayed at home Monday after being diagnosed with Covid-19, Agencia Brasil reported. Alckin is also Minister of Development, Industry, Trade, and Services.

  • Thursday, January 11th 2024 - 11:06 UTC

    Brazilian-developed vaccine against Covid-19 registered by Anvisa

    The recombinant Zalika vaccine is monovalent for the original SARS-CoV-2 virus

    The new vaccine against Covid-19 developed by the Brazilian company Zalika Farmacêutica has been entered into the National Health Surveillance Agency (Anvisa) this week, Agencia Brasil reported. The drug can be used in people aged 12 and over and is to be administered in two doses, 21 days apart, with boosters after 6 months for those over 18 years of age.

  • Saturday, November 26th 2022 - 10:12 UTC

    Brazilian-developed COVID-19 vax begins clinical trials

    After the first two phases, a report will be sent to the National Health Surveillance Agency (Anvisa) for authorization of the next phase.

    Volunteers were given Friday their first injections of SpiN-Tec MCTI UFMG, a vaccine against COVID-19 developed in Brazil “with national technology and inputs” and “financed with resources from Brazilian institutions,” according to Agencia Brasil.

Previous